The use of proteasome inhibitors to treat cancer has been greatly limited by the ability of cancer cells to develop resistance to these drugs. But researchers have found a mechanism underlying this resistance – a mechanism that naturally occurs in many diverse cancer types and that may expose vulnerabilities to drugs that spur the natural cell-death process.
from Top Health News – ScienceDaily http://ift.tt/2hi4BKw
from Tumblr http://ift.tt/2ilJ05Q
No comments:
Post a Comment